TAP vs TMCI · rev $13.04B vs rev $92.6M
TAP (TAP) versus Treace Medical Concepts Inc (TMCI) — a side-by-side from cached financials, not a winner call.
TAP (TAP) common stock.
Treace Medical Concepts Inc (TMCI) is a medical devices company listed on NASDAQ.
Latest reported TAP revenue for 2025-12-31 was $13.04B. Net income was -$2.14B. Revenue was down 5.1% from 2024-12-31 to 2025-12-31. TAP currently screens at market cap $0.
Latest reported TMCI revenue for 2026-06-30 was $92.6M. Net income was -$33.8M. Revenue was up 96.1% from 2026-03-31 to 2026-06-30. TMCI currently screens at market cap $260.1M.
TAP currently screens at market cap $0. TMCI currently screens at market cap $260.1M.
Not investment advice. Open the TAP and TMCI stock pages for the full models.
Not investment advice.